Define Ventures

Define Ventures is an early-stage venture capital firm dedicated exclusively to investing in digital health companies. The firm collaborates with entrepreneurs who possess the necessary focus and expertise in digital health, aiming to transform healthcare and improve the lives of individuals. By concentrating on this specific sector, Define Ventures seeks to support innovative solutions that can effectively address the evolving challenges within the healthcare landscape.

Kristi Ebong

Investor

Chuka Esiobu

Senior Associate

Lynne Chou O'Keefe

Founder and Managing Partner

Chirag Shah

Partner

32 past transactions

Intrinsic

Venture Round in 2023
Intrinsic Brands is an eCommerce acquisition and growth platform uniquely focused on digital-first health and wellness brands.

Soda Health

Series A in 2022
Soda Health is a healthcare technology company focused on building solutions that eliminate health inequities and create a healthier America.

Concert Health

Series B in 2022
Concert Health, Inc. is a company based in San Diego, California, that specializes in integrating behavioral health services into medical practices. Founded in 2016, it operates an online platform that connects physicians with therapists and psychiatrists, facilitating the integration of screening, therapy, and psychiatric consultations into healthcare workflows. The company provides a range of services, including remote clinical staffing with behavioral care managers and psychiatric consultants, as well as tools for registry, screening, documentation, and billing support. Concert Health aims to enhance the quality of behavioral healthcare through evidence-based practices while enabling physician practices to capitalize on new reimbursement opportunities, particularly under Medicare's Collaborative Care Management framework.

Waltz Health

Series A in 2022
Waltz Health operates in the pharmaceutical supply chain, focusing on creating innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company develops consumer tools aimed at guiding decisions related to prescription care, with a particular emphasis on the needs of both payers and consumers. By utilizing AI-driven marketplaces, Waltz Health seeks to reduce costs and enhance the decision-making process for users. Their offerings provide better pricing information and resources that empower consumers while assisting payers in managing their pharmacy benefits more effectively.

9amHealth

Series A in 2022
9am.health redesigns all care elements into one digital service individualized around today’s reality of people’s life - always available and convenient, at prices anyone can afford even without insurance. 9am.health focuses on chronic conditions such as diabetes, hypertension, and hyperlipidemia for customers in the United States.

Story Health

Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtual clinical care software tools aimed at assisting healthcare specialists, particularly neurologists and primary care physicians. The company's platform utilizes data from high-frequency sources to enhance clinical decision-making and improve patient therapy management. By integrating virtual protocols and adaptive machine learning, Story Health empowers clinicians to bridge the gap between clinical evidence and patient realities. Its focus on patient-centered design facilitates a deeper understanding of the physiological effects of diseases and therapies, ultimately aiming to optimize patient care and outcomes in specialty healthcare settings.

DexCare

Series B in 2022
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Found

Series B in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.

MedArrive

Series A in 2021
MedArrive, Inc. owns and operates a software-as-a-service technology health platform. It enables healthcare providers to extend care services through integrated care management platform. It also integrates clinical data into electronic medical records software and provides communication and billing capabilities. The company is based in New York, New York.

Lightship

Series C in 2021
Lightship is a provider of enterprise-level, direct-to-patient clinical research solutions. The company engages patients at home from recruitment through completion and eliminates the hurdles and inefficiencies of traditional approaches. Founded in 2018, Lightship is based in El Segundo, California.

Centivo

Venture Round in 2021
Centivo Corporation is a health plan administrator that provides innovative health insurance solutions for self-funded employers, employees, and clinicians. Founded in 2016 and based in Stamford, Connecticut, with additional offices in New York and Buffalo, the company aims to deliver high-quality, affordable healthcare by facilitating partnerships between employers and primary care teams. Centivo offers a comprehensive suite of services, including technology, claims processing, customer support, and population health management, to efficiently administer health benefits. Its model emphasizes collaboration between members and their primary care providers, encouraging cost-effective healthcare choices. Members benefit from personalized tools for patient-doctor matching and receive support through a user-friendly app and concierge services. Employers are supported by Centivo's commitment to eliminating waste and ensuring accountability in performance.

9amHealth

Seed Round in 2021
9am.health redesigns all care elements into one digital service individualized around today’s reality of people’s life - always available and convenient, at prices anyone can afford even without insurance. 9am.health focuses on chronic conditions such as diabetes, hypertension, and hyperlipidemia for customers in the United States.

Tia

Series B in 2021
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically. Tia is backed by leading healthcare and consumer funds, including Torch Capital, Define Ventures, Homebrew, Threshold Ventures, and Acme Ventures.

Soda Health

Seed Round in 2021
Soda Health is a healthcare technology company focused on building solutions that eliminate health inequities and create a healthier America.

Intrinsic

Series A in 2021
Intrinsic Brands is an eCommerce acquisition and growth platform uniquely focused on digital-first health and wellness brands.

Cohere Health

Series B in 2021
Cohere Health, Inc., founded in 2019 and headquartered in Boston, Massachusetts, develops a software platform aimed at enhancing collaboration among healthcare stakeholders. The company focuses on improving the patient journey by creating a user-friendly experience for patients, healthcare providers, and health plans. Its mission includes increasing the quality of care, reducing overall healthcare costs, and fostering transparency throughout the patient care process. By leveraging technology, Cohere Health seeks to address the complexities of healthcare delivery, ultimately benefiting all parties involved.

DexCare

Series A in 2021
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Unite Us

Series C in 2021
Unite Us is a veteran-led technology company that builds coordinated care networks connecting health and social service providers together. The company helps systems and communities efficiently deliver care and services by inter-connecting providers across communities, seamlessly integrating the social determinants of health into patient care. Providers across the continuum and community are able to externally refer and track every patient’s total health journey, while reporting on all tangible outcomes across a full range of services in a centralized, cohesive, and collaborative ecosystem. This social infrastructure helps communities move beyond legacy resource directories, and transform their ability to measure impact, improved health, and outcomes at scale.

Folx Health

Series A in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Found

Seed Round in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.

Found

Series A in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.

Story Health

Seed Round in 2020
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtual clinical care software tools aimed at assisting healthcare specialists, particularly neurologists and primary care physicians. The company's platform utilizes data from high-frequency sources to enhance clinical decision-making and improve patient therapy management. By integrating virtual protocols and adaptive machine learning, Story Health empowers clinicians to bridge the gap between clinical evidence and patient realities. Its focus on patient-centered design facilitates a deeper understanding of the physiological effects of diseases and therapies, ultimately aiming to optimize patient care and outcomes in specialty healthcare settings.

Centivo

Series B in 2020
Centivo Corporation is a health plan administrator that provides innovative health insurance solutions for self-funded employers, employees, and clinicians. Founded in 2016 and based in Stamford, Connecticut, with additional offices in New York and Buffalo, the company aims to deliver high-quality, affordable healthcare by facilitating partnerships between employers and primary care teams. Centivo offers a comprehensive suite of services, including technology, claims processing, customer support, and population health management, to efficiently administer health benefits. Its model emphasizes collaboration between members and their primary care providers, encouraging cost-effective healthcare choices. Members benefit from personalized tools for patient-doctor matching and receive support through a user-friendly app and concierge services. Employers are supported by Centivo's commitment to eliminating waste and ensuring accountability in performance.

MedArrive

Seed Round in 2020
MedArrive, Inc. owns and operates a software-as-a-service technology health platform. It enables healthcare providers to extend care services through integrated care management platform. It also integrates clinical data into electronic medical records software and provides communication and billing capabilities. The company is based in New York, New York.

Cohere Health

Series A in 2020
Cohere Health, Inc., founded in 2019 and headquartered in Boston, Massachusetts, develops a software platform aimed at enhancing collaboration among healthcare stakeholders. The company focuses on improving the patient journey by creating a user-friendly experience for patients, healthcare providers, and health plans. Its mission includes increasing the quality of care, reducing overall healthcare costs, and fostering transparency throughout the patient care process. By leveraging technology, Cohere Health seeks to address the complexities of healthcare delivery, ultimately benefiting all parties involved.

Tia

Series A in 2020
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically. Tia is backed by leading healthcare and consumer funds, including Torch Capital, Define Ventures, Homebrew, Threshold Ventures, and Acme Ventures.

Folx Health

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Found

Seed Round in 2020
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.

Verana Health

Series D in 2020
Innovation in healthcare is hindered by the time and cost of bringing new products to market. Verana Health is partnering with medical associations to build a regulatory-grade data platform for health care innovation that utilizes specialty clinical data sets. Verana Health’s platform enables physicians and industry to work together towards their shared goal of accelerating the availability of better treatments and cures for patients. Learn more at veranahealth.com.

Lightship

Series B in 2020
Lightship is a provider of enterprise-level, direct-to-patient clinical research solutions. The company engages patients at home from recruitment through completion and eliminates the hurdles and inefficiencies of traditional approaches. Founded in 2018, Lightship is based in El Segundo, California.

Unite Us

Series B in 2019
Unite Us is a veteran-led technology company that builds coordinated care networks connecting health and social service providers together. The company helps systems and communities efficiently deliver care and services by inter-connecting providers across communities, seamlessly integrating the social determinants of health into patient care. Providers across the continuum and community are able to externally refer and track every patient’s total health journey, while reporting on all tangible outcomes across a full range of services in a centralized, cohesive, and collaborative ecosystem. This social infrastructure helps communities move beyond legacy resource directories, and transform their ability to measure impact, improved health, and outcomes at scale.

Tia

Seed Round in 2019
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically. Tia is backed by leading healthcare and consumer funds, including Torch Capital, Define Ventures, Homebrew, Threshold Ventures, and Acme Ventures.